Abstract

This is the first report of an efficient and effective procedure to optimize the biosynthesis of huperzine A (HupA) and huperzine B (HupB) in vitro from Huperzia selago gametophytes. Axenic tissue cultures were established using spores collected from the sporophytes growing in the wild. The prothalia were obtained after 7–18 months. Approximately 90 up to 100% of the gametophytes were viable and grew rapidly after each transfer on to a fresh medium every 3 months. The best biomass growth index for prothallus calculated on a fresh (FW) and dry weight (DW) basis, at 24 weeks of culture, was 2500% (FW) and 2200% (DW), respectively. The huperzine A content in the gametophytes was very high and ranged from 0.74 mg/g to 4.73 mg/g DW. The highest yield HupA biosynthesis at >4 mg/g DW was observed on W/S medium without growth regulators at 8 to 24 weeks of culture. The highest HupB content ranged from 0.10 mg/g to 0.52 mg/g DW and was obtained on the same medium. The results demonstrate the superiority of H. selago gametophyte cultures, with the level of HupA biosynthesis approximately 42% higher compared to sporophyte cultures and 35-fold higher than when the alkaloid was isolated from H. serrata, its current source for the pharmaceutical industry. Moreover, the biosynthesis of HupB was several-fold more efficient than in H. selago sporophytes growing in the wild. HPLC-HR-MS analyses of the extracts identified eight new alkaloids previously unreported in H. selago: deacetylfawcettine, fawcettimine, 16-hydroxyhuperzine B, deacetyllycoclavine, annopodine, lycopecurine, des-N-methylfastigiatine and flabelline.

Highlights

  • Huperzine A (HupA, selagine) and huperzine B (HupB) are two alkaloids which were first isolated from two Lycopodium species in the family Huperziaceae: Huperzia serrata and Huperzia selago [1,2,3,4]

  • This paper presents a protocol for a fast and effective in vitro axenic culture of Huperzia selago (L.)

  • The major therapeutic interest described for huperzine A (HupA) is as treatment for acetylcholine-deficit dementia, including Alzheimer’s disease [6]

Read more

Summary

Introduction

Huperzine A (HupA, selagine) and huperzine B (HupB) are two alkaloids which were first isolated from two Lycopodium species in the family Huperziaceae: Huperzia serrata and Huperzia selago (formerly known as L. selago) [1,2,3,4]. HupA has been found to prevent apoptosis of neurons responsible for cognition and memory via reducing oxidative stress, stimulating expression of the neuronal growth factor (NGF) gene and NGF secretion and modifying β-amyloid transformation [6,7,10,11]. Studies suggest that pharmacological properties of HupA result from its effect on the genes coding for proteins of the Bcl-2 family, Bax and p53 [6,7,11]. In an experimental rat model, after administration of HupA followed by apoptosis-promoting stressors, proapoptotic cytosolic alterations and decreased expression of BCL2, BAX and TP53 genes were observed [6,7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call